BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• 

  Business

  Five Biggest Drug Face-Offs in Pharma History

  Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.

  April 9, 2025

   · 

  9 min read

   · 

  Tristan Manalac
• 

  Tariffs

  Pharmas Bleed Value as Trump Tariffs Roil Global Markets

  Billions in market cap are being shed as the markets reel over President Donald Trump’s escalating trade war. Eli Lilly’s value has dropped more than $95 billion in just one month.

  April 9, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Podcast

  Tariff-Triggered Recession Fears, Fallout From HHS Cuts, Knockoff GLP-1s and More

  A consumer-driven weight loss market could put pharma at greater risk if a recession hits; the continued turmoil at FDA and other HHS agencies magnifies the uncertainty facing the industry; Lilly files a lawsuit against a med spa selling its drugs; and more.

  April 9, 2025

   · 

  1 min read

   · 

  Heather McKenzie
• 

  China

  Amid Trade Tensions, Commission Warns China is ‘Dangerously Close’ to Overtaking US Biotech

  The National Security Commission on Emerging Biotechnology recommends at least a $15 billion investment into biotech over the next five years.

  April 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Legal

  BMS Scores Two on Tuesday With Colorectal Cancer Approval, Court Win

  The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action complaint over the blood cancer drug Pomalyst.

  April 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Tariffs

  ‘Put On Your Life Vest’: Pharma Tariffs Are Coming

  As the industry awaits official word from the administration on how the tariffs will hit, analysts go over the possibilities with one certainty: there will be increased costs for medicines.

  April 9, 2025

   · 

  5 min read

   · 

  Annalee Armstrong
• 

  Tariffs

  Trump Says ‘Major’ Pharma Tariffs Coming ‘Very Shortly’ After Sparing Industry on Liberation Day

  Analysts suggested that the tariffs will have little effect on reshoring manufacturing and will likely decrease patient drug access and increase costs.

  April 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Legal

  Jazz Settles for $145M in Anti-Trust Suits Centering on Xyrem Generics

  Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the market.

  April 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

  April 9, 2025

   · 

  5 min read
• Press Releases

  Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

  April 9, 2025

   · 

  7 min read